E Minar

Measurement and Interpretation of the Ankle-Brachial Index

Complement Factor H Polymorphism and Age-Related Macular Degeneration

Heparin-induced thrombocytopenia (HIT)

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

The Metabolic Syndrome and Inflammation

Individually tailored duration of elastic compression therapy in relation to incidence of the postthrombotic syndrome

Cyclosporine A enhances platelet aggregation

Abdominal obesity and metabolic syndrome

Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months

A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors

Venous thromboembolism: disease burden, outcomes and risk factors

Mechanisms linking obesity with cardiovascular disease

Ultrasound in the detection of venous thromboembolism

The metabolic syndrome

Bariatric Surgery

Early Results of Thrombolysis vs Anticoagulation in Iliofemoral Venous Thrombosis. A Randomised Clinical Trial

Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials

Antithrombotic Therapy for VTE Disease

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis

Adipokines: molecular links between obesity and atheroslcerosis

Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients

Multidetector Computed Tomography for Acute Pulmonary Embolism

Abdominal Aortic Aneurysms: Cost-effectiveness of Elective Endovascular and Open Surgical Repair

GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

Long-Term Mortality after Gastric Bypass Surgery

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Thrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events

Diagnosis of DVT

High D‐dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Antithrombotic Therapy for VTE Disease

AneuRx stent graft versus open surgical repair of abdominal aortic aneurysms: Multicenter prospective clinical trial

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

The metabolic syndrome

The metabolic syndrome and cardiovascular disease

Statin effects beyond lipid lowering—are they clinically relevant?

Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery

Heparin-Induced Thrombocytopenia

Primary Patency of Femoropopliteal Arteries Treated with Nitinol versus Stainless Steel Self-expanding Stents: Propensity Score–adjusted Analysis

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

Clinical Validity of a Negative Computed Tomography Scan in Patients With Suspected Pulmonary Embolism

Prospects for the use of antagonists to the platelet glycoprotein IIb/ IIIa receptor to prevent postangioplasty restenosis and thrombosis

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

A Randomized Trial Comparing Conventional and Endovascular Repair of Abdominal Aortic Aneurysms

Antiatherothrombotic Properties of Statins

Treatment of subclavian–axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis

The Role of Cytokines in Non-Alcoholic Fatty Liver Disease

Obesity, Inflammation, and Insulin Resistance

Aspirin Dose for the Prevention of Cardiovascular Disease

Cyclosporine

The cost-effectiveness of endovascular repair versus open surgical repair of abdominal aortic aneurysms: A decision analysis model

Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review

Antithrombotic Therapy for Venous Thromboembolic Disease

Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure

Oral Anticoagulant Drugs

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

Elective Endovascular versus Open Surgical Repair of Abdominal Aortic Aneurysms: Systematic Review of Short-term Results

Inflammatory markers and particulate air pollution: characterizing the pathway to disease

Frailty in elderly people

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

Abdominal Aortic Aneurysms: Elective Endovascular Repair versus Conventional Surgery—Evaluation with Evidence-based Medicine Techniques

Human health implications of environmental contaminants in Arctic Canada: a review

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review

Bariatric Surgery and Cardiovascular Risk Factors

Extracellular DNA traps promote thrombosis

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

Diagnosis and Management of the Metabolic Syndrome

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Adipose Tissue, Inflammation, and Cardiovascular Disease

Antibodies Against the Fibrin β-Chain Amino-Terminus Detect Active Canine Venous Thrombi

Endovascular Brachytherapy for Prophylaxis of Restenosis After Femoropopliteal Angioplasty

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Complications of heparin administration in normal individuals

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis

Meta-Analysis: Outcomes in Patients with Suspected Pulmonary Embolism Managed with Computed Tomographic Pulmonary Angiography

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Transaminase Elevations in Patients Receiving Bovine or Porcine Heparin

A cost-effectiveness analysis of standard versus endovascular abdominal aortic aneurysm repair.

Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease

Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis

Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism

Exercise and Toll-like receptors.

Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention

Human Fatty Liver Disease: Old Questions and New Insights

Particulate Matter Air Pollution and Cardiovascular Disease

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Low-Molecular-Weight Heparins

The Epidemiology of Venous Thromboembolism in the Community: Implications for Prevention and Management

Below-Knee Elastic Compression Stockings To Prevent the Post-Thrombotic Syndrome

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

Antithrombotic Therapy for Venous Thromboembolic Disease

Obesity Is an Important Determinant of Baseline Serum C-Reactive Protein Concentration in Monozygotic Twins, Independent of Genetic Influences

Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).

Endovascular management of “Endoleaks” after transluminal infrarenal abdominal aneurysm repair

Deep vein thrombosis: scintigraphic diagnosis with In-111-labeled monoclonal antifibrin antibodies.

Value of negative spiral CT angiography in patients with suspected acute PE: analysis of PE occurrence and outcome

Deep venous thrombosis of the lower extremity: efficacy of spiral CT venography compared with conventional venography in diagnosis.

Effect of lovastatin on hemorheology in type II hyperlipoproteinemia

Post-thrombotic Syndrome After Primary Event of Deep Venous Thrombosis 10 to 20 Years Ago

Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study.

Outcome of Conservative Therapy of Patients with Severe Intermittent Claudication

The risk of recurrent venous thromboembolism among patients with high factor IX levels

A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries

The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease

Influence of anticoagulant treatment in preventing graft occlusion following saphenous vein bypass for femoropopliteal occlusive disease

INFLUENCE OF POSTOPERATIVE ANTICOAGULANT TREATMENT ON PATIENT SURVIVAL AFTER FEMOROPOPLITEAL VEIN BYPASS SURGERY

Comparison of Effects of High-Dose and Low-Dose Aspirin on Restenosis After Femoropopliteal Percutaneous Transluminal Angioplasty

VENOUS THROMBOSIS AND CYCLOSPORIN

The first 15 months of transluminal abdominal aortic aneurysm management: A single centre experience

Endovascular AAA treatment: Expensive prestige or economic alternative?

The influence of anticoagulant treatment on the probability of function in femoropopliteal vein bypass surgery: analysis of a clinical series (1970 to 1985) and interim evaluation of a controlled clinical trial.

Prevention of pulmonary embolism

Prevention of postvenographic thrombosis by heparin flush: fibrinogen uptake measurements

Platelet Deposition at Angioplasty Sites and Platelet Survival Time After PTA in lliac and Femoral Arteries: Investigations with Indium-111-Oxine Labelled Platelets in Patients with ASA (1.0 g/Day)-Therapy

Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

Transaminasenanstieg: eine weitgehend unbekannte Nebenwirkung der Heparintherapie

[Thrombolysis using urokinase in acute phlebothrombosis].